SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-22-004514
Filing Date
2022-06-23
Accepted
2022-06-23 16:33:34
Documents
1
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4216
  Complete submission text file 0001171843-22-004514.txt   5586
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3
Business Address
D'Alvise Janelle (Reporting) CIK: 0001807412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35776 | Film No.: 221035908